{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T12:19:40Z","timestamp":1789042780010,"version":"build-2803163510"},"reference-count":54,"publisher":"Impact Journals, LLC","issue":"17","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Aging"],"published-print":{"date-parts":[[2023,9,15]]},"DOI":"10.18632\/aging.205005","type":"journal-article","created":{"date-parts":[[2023,9,8]],"date-time":"2023-09-08T14:42:43Z","timestamp":1694184163000},"page":"8908-8929","source":"Crossref","is-referenced-by-count":15,"title":["TIMP1 shapes an immunosuppressive microenvironment by regulating anoikis to promote the progression of clear cell renal cell carcinoma"],"prefix":"10.18632","volume":"15","author":[{"given":"Qiang","family":"Li","sequence":"first","affiliation":[{"name":"Department of Urology, The First Affiliated Hospital of Soochow University, Suzhou 215006, China"},{"name":"Department of Urology, The Affiliated Jiangsu Shengze Hospital of Nanjing Medical University, Suzhou 215228, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kai","family":"Wei","sequence":"additional","affiliation":[{"name":"Department of Urology, The Second Affiliated Hospital of Soochow University, Suzhou 215004, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xi","family":"Zhang","sequence":"additional","affiliation":[{"name":"The State Key Lab of Reproductive, Department of Urology, The First Affiliated Hospital of Nanjing Medical University, Nanjing 210029, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Lv","sequence":"additional","affiliation":[{"name":"Department of Urology, The Affiliated Jiangsu Shengze Hospital of Nanjing Medical University, Suzhou 215228, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miao","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Urology, The First Affiliated Hospital of Soochow University, Suzhou 215006, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chenchao","family":"Zhou","sequence":"additional","affiliation":[{"name":"Department of Urology, The First Affiliated Hospital of Soochow University, Suzhou 215006, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shifeng","family":"Su","sequence":"additional","affiliation":[{"name":"The State Key Lab of Reproductive, Department of Urology, The First Affiliated Hospital of Nanjing Medical University, Nanjing 210029, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daorong","family":"Hou","sequence":"additional","affiliation":[{"name":"Key Laboratory of Model Animal Research, Animal Core Facility of Nanjing Medical University, Nanjing Medical University, Nanjing 211166, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianquan","family":"Hou","sequence":"additional","affiliation":[{"name":"Department of Urology, The First Affiliated Hospital of Soochow University, Suzhou 215006, China"},{"name":"Department of Urology, Dushu Lake Hospital Affiliated to Soochow University, Suzhou 215000, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"7892","published-online":{"date-parts":[[2023,9,8]]},"reference":[{"key":"1","doi-asserted-by":"publisher","first-page":"913","DOI":"10.1016\/j.eururo.2015.01.005","article-title":"EAU guidelines on renal cell carcinoma: 2014 update.","volume":"6","author":"Staehler","year":"2015","journal-title":"Eur Urol"},{"key":"2","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/j.ccell.2022.12.001","article-title":"Histopathologic and proteogenomic heterogeneity reveals features of clear cell renal cell carcinoma aggressiveness.","volume":"4","author":"Zhao","year":"2023","journal-title":"Cancer Cell"},{"key":"3","doi-asserted-by":"publisher","first-page":"507","DOI":"10.3322\/caac.21411","article-title":"Treatment of renal cell carcinoma: Current status and future directions.","volume":"6","author":"Rini","year":"2017","journal-title":"CA Cancer J Clin"},{"key":"4","doi-asserted-by":"publisher","first-page":"394","DOI":"10.3322\/caac.21492","article-title":"Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.","volume":"6","author":"Jemal","year":"2018","journal-title":"CA Cancer J Clin"},{"key":"5","doi-asserted-by":"publisher","first-page":"700","DOI":"10.1158\/0008-5472.CAN-22-2224","article-title":"Integrative Single-Cell Analysis Reveals Transcriptional and Epigenetic Regulatory Features of Clear Cell Renal Cell Carcinoma.","volume":"8","author":"Guo","year":"2023","journal-title":"Cancer Res"},{"key":"6","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1016\/j.eururo.2020.09.027","article-title":"The Clinicopathologic and Molecular Landscape of Clear Cell Papillary Renal Cell Carcinoma: Implications in Diagnosis and Management.","volume":"7","author":"Reznik","year":"2021","journal-title":"Eur Urol"},{"key":"7","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1007\/s11912-020-0892-1","article-title":"Current State of Systemic Therapies for Advanced Renal Cell Carcinoma.","volume":"2","author":"Vaishampayan","year":"2020","journal-title":"Curr Oncol Rep"},{"key":"8","doi-asserted-by":"publisher","first-page":"1767","DOI":"10.1056\/NEJMoa2212851","article-title":"Cabozantinib plus Nivolumab and Ipilimumab in Renal-Cell Carcinoma.","volume":"38","author":"Wang","year":"2023","journal-title":"N Engl J Med"},{"key":"9","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1016\/j.eururo.2021.04.031","article-title":"Systemic Therapy for Advanced Non-clear-Cell Renal Cell Carcinoma: Slow but Definite Progress.","volume":"8","author":"Plimack","year":"2021","journal-title":"Eur Urol"},{"key":"10","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1186\/s12943-015-0321-5","article-title":"Apoptosis, autophagy, necroptosis, and cancer metastasis.","volume":"1","author":"Yu","year":"2015","journal-title":"Mol Cancer"},{"key":"11","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1038\/s41571-020-0341-y","article-title":"Targeting apoptosis in cancer therapy.","volume":"1","author":"El-Deiry","year":"2020","journal-title":"Nat Rev Clin Oncol"},{"key":"12","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1186\/s12943-023-01732-y","article-title":"Cuproptosis: mechanisms and links with cancers.","volume":"2","author":"He","year":"2023","journal-title":"Mol Cancer"},{"key":"13","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1016\/j.trecan.2023.02.001","article-title":"Cell death, therapeutics, and the immune response in cancer.","volume":"9","author":"Ruffell","year":"2023","journal-title":"Trends Cancer"},{"key":"14","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1002\/path.3000","article-title":"Anoikis: an emerging hallmark in health and diseases.","volume":"22","author":"Chiarugi","year":"2012","journal-title":"J Pathol"},{"key":"15","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1016\/j.mam.2010.02.001","article-title":"Targeting anoikis resistance in prostate cancer metastasis.","volume":"3","author":"Kyprianou","year":"2010","journal-title":"Mol Aspects Med"},{"key":"16","doi-asserted-by":"publisher","first-page":"1473","DOI":"10.1038\/sj.cdd.4401723","article-title":"Anoikis.","volume":"1","author":"Gilmore","year":"2005","journal-title":"Cell Death Differ"},{"key":"17","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/j.canlet.2008.05.029","article-title":"Anoikis resistance and tumor metastasis.","volume":"27","author":"Schimmer","year":"2008","journal-title":"Cancer Lett"},{"key":"18","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1016\/s0955-0674(00)00251-9","article-title":"Anoikis mechanisms.","volume":"1","author":"Screaton","year":"2001","journal-title":"Curr Opin Cell Biol"},{"key":"19","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1080\/01926230701320337","article-title":"Apoptosis: a review of programmed cell death.","volume":"3","author":"Elmore","year":"2007","journal-title":"Toxicol Pathol"},{"key":"20","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1016\/j.apsb.2015.07.005","article-title":"Cancer metastases: challenges and opportunities.","volume":"5","author":"Guan","year":"2015","journal-title":"Acta Pharm Sin B"},{"key":"21","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1038\/s41419-018-1242-1","article-title":"Acidosis enhances the self-renewal and mitochondrial respiration of stem cell-like glioma cells through CYP24A1-mediated reduction of vitamin D.","volume":"1","author":"Yuan","year":"2019","journal-title":"Cell Death Dis"},{"key":"22","doi-asserted-by":"publisher","first-page":"159","DOI":"10.3389\/fonc.2019.00159","article-title":"Therapeutic Targeting of Cancer Stem Cells: Integrating and Exploiting the Acidic Niche.","volume":"9","author":"Corbet","year":"2019","journal-title":"Front Oncol"},{"key":"23","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1186\/s13287-019-1265-2","article-title":"Elevated level of mitochondrial reactive oxygen species via fatty acid \u03b2-oxidation in cancer stem cells promotes cancer metastasis by inducing epithelial-mesenchymal transition.","volume":"1","author":"Zhu","year":"2019","journal-title":"Stem Cell Res Ther"},{"key":"24","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1002\/(sici)1097-0215(19990219)84:1<44::aid-ijc9>3.0.co;2-p","article-title":"High levels of tissue inhibitor of metalloproteinase-1 predict poor outcome in patients with breast cancer.","volume":"8","author":"Duffy","year":"1999","journal-title":"Int J Cancer"},{"key":"25","doi-asserted-by":"publisher","first-page":"2289","DOI":"10.1158\/1078-0432.ccr-03-0360","article-title":"Tumor tissue levels of tissue inhibitor of metalloproteinase-1 as a prognostic marker in primary breast cancer.","volume":"1","author":"Foekens","year":"2004","journal-title":"Clin Cancer Res"},{"key":"26","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1080\/02841860802022976","article-title":"TIMP-1 as a tumor marker in breast cancer--an update.","volume":"4","author":"Br\u00fcnner","year":"2008","journal-title":"Acta Oncol"},{"key":"27","doi-asserted-by":"publisher","first-page":"15935","DOI":"10.1074\/jbc.M112.341156","article-title":"Matrix metalloproteinase-10 (MMP-10) interaction with tissue inhibitors of metalloproteinases TIMP-1 and TIMP-2: binding studies and crystal structure.","volume":"28","author":"Radisky","year":"2012","journal-title":"J Biol Chem"},{"key":"28","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1186\/1476-4598-12-22","article-title":"Timp1 interacts with beta-1 integrin and CD63 along melanoma genesis and confers anoikis resistance by activating PI3-K signaling pathway independently of Akt phosphorylation.","volume":"1","author":"Jasiulionis","year":"2013","journal-title":"Mol Cancer"},{"key":"29","doi-asserted-by":"publisher","first-page":"7342","DOI":"10.1038\/s41598-017-07191-y","article-title":"Recognizing the Continuous Nature of Expression Heterogeneity and Clinical Outcomes in Clear Cell Renal Cell Carcinoma.","volume":"7","author":"Nicol","year":"2017","journal-title":"Sci Rep"},{"key":"30","doi-asserted-by":"publisher","first-page":"e0148746","DOI":"10.1371\/journal.pone.0148746","article-title":"Integrated microRNA and mRNA Signature Associated with the Transition from the Locally Confined to the Metastasized Clear Cell Renal Cell Carcinoma Exemplified by miR-146-5p.","volume":"1","author":"Meyer","year":"2016","journal-title":"PLoS One"},{"key":"31","doi-asserted-by":"publisher","first-page":"726","DOI":"10.1158\/2326-6066.CIR-16-0072","article-title":"The Intratumoral Balance between Metabolic and Immunologic Gene Expression Is Associated with Anti-PD-1 Response in Patients with Renal Cell Carcinoma.","volume":"4","author":"Pardoll","year":"2016","journal-title":"Cancer Immunol Res"},{"key":"32","doi-asserted-by":"publisher","first-page":"1135","DOI":"10.1038\/nbt1209-1135","article-title":"How does multiple testing correction work?","volume":"2","author":"Noble","year":"2009","journal-title":"Nat Biotechnol"},{"key":"33","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1186\/1471-2105-11-367","article-title":"A flexible R package for nonnegative matrix factorization.","volume":"1","author":"Seoighe","year":"2010","journal-title":"BMC Bioinformatics"},{"key":"34","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/1471-2105-14-7","article-title":"GSVA: gene set variation analysis for microarray and RNA-seq data.","volume":"1","author":"Guinney","year":"2013","journal-title":"BMC Bioinformatics"},{"key":"35","doi-asserted-by":"publisher","first-page":"1747","DOI":"10.1101\/gr.239244.118","article-title":"Maftools: efficient and comprehensive analysis of somatic variants in cancer.","volume":"2","author":"Koeffler","year":"2018","journal-title":"Genome Res"},{"key":"36","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1038\/nrurol.2010.46","article-title":"Epidemiology and risk factors for kidney cancer.","volume":"7","author":"Devesa","year":"2010","journal-title":"Nat Rev Urol"},{"key":"37","doi-asserted-by":"publisher","first-page":"102971","DOI":"10.1016\/j.critrevonc.2020.102971","article-title":"Systemic therapy in metastatic renal cell carcinoma: Emerging challenges in therapeutic choice.","volume":"15","author":"Chan","year":"2020","journal-title":"Crit Rev Oncol Hematol"},{"key":"38","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1016\/s0955-0674(97)80124-x","article-title":"Integrins and anoikis.","volume":"9","author":"Ruoslahti","year":"1997","journal-title":"Curr Opin Cell Biol"},{"key":"39","doi-asserted-by":"publisher","first-page":"11230","DOI":"10.1158\/0008-5472.CAN-05-2763","article-title":"Anoikis and survival connections in the tumor microenvironment: is there a role in prostate cancer metastasis?","volume":"6","author":"Kyprianou","year":"2005","journal-title":"Cancer Res"},{"key":"40","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1016\/s0092-8674(04)00046-7","article-title":"Cell death: critical control points.","volume":"11","author":"Korsmeyer","year":"2004","journal-title":"Cell"},{"key":"41","doi-asserted-by":"publisher","first-page":"6025","DOI":"10.1038\/s41388-018-0384-z","article-title":"CPT1A-mediated fatty acid oxidation promotes colorectal cancer cell metastasis by inhibiting anoikis.","volume":"3","author":"Wang","year":"2018","journal-title":"Oncogene"},{"key":"42","doi-asserted-by":"publisher","first-page":"1154","DOI":"10.1038\/s41416-020-0970-z","article-title":"IQGAP1 promotes anoikis resistance and metastasis through Rac1-dependent ROS accumulation and activation of Src\/FAK signalling in hepatocellular carcinoma.","volume":"12","author":"Zou","year":"2020","journal-title":"Br J Cancer"},{"key":"43","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1038\/cdd.2012.136","article-title":"CCN2 inhibits lung cancer metastasis through promoting DAPK-dependent anoikis and inducing EGFR degradation.","volume":"2","author":"Kuo","year":"2013","journal-title":"Cell Death Differ"},{"key":"44","doi-asserted-by":"publisher","first-page":"3375297","DOI":"10.1155\/2021\/3375297","article-title":"Development of Biomarker Signatures Associated with Anoikis to Predict Prognosis in Endometrial Carcinoma Patients.","volume":"202","author":"Ge","year":"2021","journal-title":"J Oncol"},{"key":"45","doi-asserted-by":"publisher","first-page":"1171883","DOI":"10.3389\/fimmu.2023.1171883","article-title":"Establishment and validation of a novel anoikis-related prognostic signature of clear cell renal cell carcinoma.","volume":"1","author":"Shao","year":"2023","journal-title":"Front Immunol"},{"key":"46","doi-asserted-by":"publisher","first-page":"1482","DOI":"10.1093\/annonc\/mdw168","article-title":"Targeting the tumor microenvironment: removing obstruction to anticancer immune responses and immunotherapy.","volume":"2","author":"Zitvogel","year":"2016","journal-title":"Ann Oncol"},{"key":"47","doi-asserted-by":"publisher","first-page":"736","DOI":"10.1016\/j.cell.2017.04.016","article-title":"An Immune Atlas of Clear Cell Renal Cell Carcinoma.","volume":"16","author":"Stadler","year":"2017","journal-title":"Cell"},{"key":"48","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.cell.2014.12.033","article-title":"Molecular and genetic properties of tumors associated with local immune cytolytic activity.","volume":"16","author":"Hacohen","year":"2015","journal-title":"Cell"},{"key":"49","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1186\/s40425-019-0621-1","article-title":"Prognostic impact of immune gene expression signature and tumor infiltrating immune cells in localized clear cell renal cell carcinoma.","volume":"7","author":"Plimack","year":"2019","journal-title":"J Immunother Cancer"},{"key":"50","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1074\/mcp.M700305-MCP200","article-title":"Plasma and serum levels of tissue inhibitor of metalloproteinases-1 are associated with prognosis in node-negative breast cancer: a prospective study.","volume":"7","author":"Br\u00fcnner","year":"2008","journal-title":"Mol Cell Proteomics"},{"key":"51","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1016\/j.ccell.2020.10.012","article-title":"Senescence Reprogramming by TIMP1 Deficiency Promotes Prostate Cancer Metastasis.","volume":"3","author":"R\u00fcschoff","year":"2021","journal-title":"Cancer Cell"},{"key":"52","doi-asserted-by":"publisher","first-page":"3354","DOI":"10.3892\/ol.2016.4391","article-title":"Variations in the expression of TIMP1, TIMP2 and TIMP3 in cutaneous melanoma with regression and their possible function as prognostic predictors.","volume":"1","author":"Caruntu","year":"2016","journal-title":"Oncol Lett"},{"key":"53","doi-asserted-by":"publisher","first-page":"1069","DOI":"10.1002\/hed.20099","article-title":"TIMP1 and SERPIN-A overexpression and TFF3 and CRABP1 underexpression as biomarkers for papillary thyroid carcinoma.","volume":"2","author":"Tan","year":"2004","journal-title":"Head Neck"},{"key":"54","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1016\/j.tcb.2022.08.005","article-title":"Cut loose TIMP-1: an emerging cytokine in inflammation.","volume":"3","author":"Kr\u00fcger","year":"2023","journal-title":"Trends Cell Biol"}],"container-title":["Aging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.aging-us.com\/lookup\/doi\/10.18632\/aging.205005","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,20]],"date-time":"2023-09-20T19:50:19Z","timestamp":1695239419000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.aging-us.com\/lookup\/doi\/10.18632\/aging.205005"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9,8]]},"references-count":54,"journal-issue":{"issue":"17","published-print":{"date-parts":[[2023,9,15]]}},"alternative-id":["205005","37688768"],"URL":"https:\/\/doi.org\/10.18632\/aging.205005","relation":{},"ISSN":["1945-4589"],"issn-type":[{"value":"1945-4589","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,9,8]]}}}